GO:0036122 BMP binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036122 (BMP binding) is a molecular function defined as binding to a member of the bone morphogenetic protein (BMP) family [QuickGO].
• BMP binding is mediated by extracellular and cell-surface proteins that control BMP ligand availability, receptor engagement, and signaling output [1,5].
• Key BMP-binding proteins include Noggin, Gremlin1, Twisted gastrulation, SPARC-related modular calcium binding 1 (SMOC1), and procollagen C-proteinase enhancer-1 (PCOLCE) [1,2,5,6,8].
• BMP binding specificity is determined by structural features of both the ligand and its binding partner, as shown for BMP-2, BMP-3, BMP-6, and BMP-9 [3,4,7].
• Dysregulated BMP binding contributes to vascular calcification, fibrosis, and cancer progression [2,6].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable functional dissection of BMP-binding proteins in disease [1,5].
Description
Bone morphogenetic proteins (BMPs) are secreted signaling molecules that belong to the transforming growth factor-beta (TGF-beta) superfamily and control cell fate, differentiation, and tissue homeostasis. The molecular function defined by GO:0036122, BMP binding, refers to the selective interaction of a protein or biomolecule with a BMP ligand [QuickGO]. This binding event is a critical node in BMP signaling because it determines whether BMPs are presented to, or sequestered from, their cognate receptors on the cell surface [1,5]. Researchers study BMP binding to understand how extracellular regulators shape morphogen gradients, how structural determinants govern ligand-receptor specificity, and how disruption of these interactions leads to human disease [2,6]. The functional repertoire of BMP-binding proteins extends beyond simple sequestration. For example, the BMP-2 mutant L51P retains noggin binding but fails to engage BMP receptor IA, illustrating that BMP binding and receptor activation are separable biochemical events. Similarly, GREMLIN1 uptake in epithelial cells requires BMP binding, linking ligand interaction to intracellular trafficking. These findings position GO:0036122 as a central molecular function for both basic developmental biology and translational research.
BMP binding At A Glance
| GO ID | GO:0036122 |
|---|---|
| GO term | BMP binding |
| Ontology | molecular_function |
| Synonym | bone morphogenetic protein binding |
| Definition | Binding to a member of the bone morphogenetic protein (BMP) family. |
| Major function | Regulation of BMP ligand availability, gradient formation, and receptor-mediated signaling. |
| Representative binders | Noggin, Gremlin1, Twisted gastrulation, SMOC1, PCOLCE, heparin oligosaccharides. |
| Disease relevance | Vascular calcification, fibrosis, cancer, and skeletal disorders. |
| Research methods | Surface plasmon resonance, isothermal titration calorimetry, CRISPR knockout, and structural biology. |
What Is GO:0036122?
GO:0036122 (BMP binding) is a molecular function term describing the binding to a member of the bone morphogenetic protein (BMP) family. In practical terms, it encompasses any direct physical interaction between a protein, carbohydrate, or other biomolecule and a BMP ligand, including BMP-2, BMP-3, BMP-4, BMP-6, BMP-7, and BMP-9. This function is distinct from BMP receptor binding, although the two are functionally coupled in signaling. The official synonym is bone morphogenetic protein binding [QuickGO].
Why Is BMP binding Important in Cell Biology?
BMP binding is important because it serves as the first checkpoint in BMP signal transduction, determining whether ligands are free to activate receptors or are sequestered in the extracellular matrix. This function controls embryonic patterning, tissue homeostasis, and repair, and its dysregulation is implicated in cardiovascular calcification, fibrosis, and cancer [2,6]. Understanding BMP binding at the molecular level informs the design of therapeutics that modulate BMP activity, such as ligand traps or engineered BMP variants [1,5].
• Controls BMP ligand bioavailability and signaling strength in development and tissue repair.
• Determines specificity between BMP ligands and their receptors [4,7].
• Regulates extracellular matrix storage and release of BMPs [3,8].
• Dysregulation contributes to aortic valve calcification and vascular disease.
• Altered BMP binding is linked to cancer progression and epithelial cell uptake pathways.
• Provides targets for engineered BMP inhibitors and ligand traps.
• Enables structural design of BMP-2 variants with altered receptor binding.
• Supports research on morphogen gradient formation and tissue patterning.
• Facilitates development of biomaterials that modulate BMP activity.
• Offers a molecular handle for CRISPR-based functional genomics of BMP signaling [1,5].
Molecular Mechanism of BMP binding
Ligand recognition and binding interface
In simple terms: BMP-binding proteins recognize specific shapes on BMP ligands.
BMP ligands are dimeric cystine-knot proteins, and their binding partners engage distinct surfaces. Structural studies of BMP-3 and BMP-6 have illuminated how binding specificity with receptors is achieved, revealing that the type I receptor interface is a major determinant of selectivity. Similarly, BMP-2 and BMP-9 binding specificities with ALK-3 have been characterized in aqueous solution using molecular dynamics, showing that electrostatic and conformational complementarity govern complex formation. These findings establish that BMP binding is not a generic interaction but depends on precise structural features of both the ligand and the binding partner.
Extracellular sequestration and gradient control
In simple terms: Some proteins bind BMPs and hold them in the extracellular space, preventing them from reaching receptors.
Twisted gastrulation is a secreted BMP-binding protein that controls BMP signal output by forming complexes with BMP ligands and other extracellular modulators. The molecular mechanism of BMP signal control by Twisted gastrulation has been resolved, showing how it competes with receptors and shapes morphogen gradients. Noggin is another well-characterized BMP antagonist; the BMP-2 mutant L51P binds noggin but fails to engage BMP receptor IA, demonstrating that ligand sequestration and receptor activation are separable. These interactions are critical for establishing BMP gradients during development and for limiting signaling in adult tissues.
Matrix and carbohydrate interactions
In simple terms: BMPs can bind to sugars and matrix proteins, which changes how they are stored and released.
Heparin oligosaccharides bind BMP-2 with a minimum structural requirement, and this interaction modulates BMP-2 activity and stability. Procollagen C-proteinase enhancer-1 (PCOLCE) participates in an extended interaction network in the extracellular matrix, where it can influence BMP availability and processing. These matrix interactions provide a reservoir for BMPs and regulate their local concentration and presentation to receptors.
Cell-surface and uptake pathways
In simple terms: Some cells take up BMP-binding proteins together with BMPs, which affects signaling inside the cell.
A novel GREMLIN1 uptake pathway in epithelial cells requires BMP binding, indicating that the BMP-binding function of GREMLIN1 is necessary for its internalization and subsequent effects on signaling. This suggests that BMP binding is not only an extracellular event but can also trigger intracellular trafficking and signaling outcomes. SMOC1 regulates aortic valve calcification by disrupting BMPR-II/p-p38 signaling, highlighting how BMP-binding proteins can act at the interface of matrix and cell-surface signaling.
Regulation of BMP binding affinity and specificity
In simple terms: The strength and selectivity of BMP binding can be tuned by mutations and post-translational modifications.
The BMP-2 mutant L51P is a BMP receptor IA binding-deficient inhibitor of noggin, showing that single amino acid changes can uncouple BMP binding from receptor activation. Structural studies of BMP-3 and BMP-6 further illustrate how sequence variation among BMP family members dictates binding specificity with receptors. These examples demonstrate that BMP binding is a tunable function that can be engineered for therapeutic purposes.
Key Genes Involved in GO:0036122 BMP binding
The following genes encode proteins and biomolecules that directly bind BMP ligands and regulate BMP signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOG | Secreted BMP antagonist that binds BMP-2, BMP-4, and others | Model for ligand sequestration and BMP gradient control |
| GREM1 | Secreted BMP antagonist; uptake requires BMP binding | Epithelial cell uptake and cancer biology |
| TWSG1 | Twisted gastrulation; modulates BMP signaling | Structural mechanism of BMP signal control |
| SMOC1 | Matricellular protein that regulates BMPR-II signaling | Aortic valve calcification |
| PCOLCE | Procollagen C-proteinase enhancer-1; matrix interaction network | Extracellular matrix and BMP availability |
| BMP2 | Ligand; binds noggin, heparin, and receptors | Structural and functional studies of BMP binding [1,3] |
| BMP3 | Ligand with distinct receptor binding specificity | Binding specificity with receptors |
| BMP6 | Ligand with distinct receptor binding specificity | Binding specificity with receptors |
| BMP9 | Ligand that binds ALK-3 | Binding specificity in aqueous solution |
| ALK3 | Type I receptor for BMPs | Receptor binding specificity |
| BMPR2 | Type II receptor for BMPs | SMOC1-mediated signaling in calcification |
| HSPG2 | Heparan sulfate proteoglycan; binds BMP-2 via heparin | Minimum structural requirements for BMP-2 binding |
| COL1A1 | Collagen; interacts with PCOLCE and BMPs | Extracellular matrix network |
| COL1A2 | Collagen; interacts with PCOLCE and BMPs | Extracellular matrix network |
| BMP4 | Ligand; binds noggin and other antagonists | Developmental signaling |
| BMP7 | Ligand; binds noggin and other antagonists | Developmental signaling |
| CHRD | Chordin; BMP-binding protein | Extracellular BMP regulation |
How Is BMP binding Regulated?
BMP binding is regulated at multiple levels. Extracellular antagonists such as Noggin and Gremlin1 compete with receptors for ligand binding, and their expression is controlled by feedback loops and developmental cues [1,2]. Twisted gastrulation modulates BMP signaling by forming complexes with BMPs and other extracellular proteins, thereby fine-tuning signal output. Matrix components, including heparin oligosaccharides and PCOLCE, influence BMP binding by altering ligand availability and stability [3,8]. Additionally, SMOC1 regulates BMPR-II/p-p38 signaling, providing a mechanism by which BMP binding can be coupled to intracellular kinase pathways. These regulatory layers ensure that BMP binding is context-dependent and responsive to tissue needs.
BMP binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMOC1 | Aortic valve calcification | Knockout and overexpression in valve interstitial cells |
| GREM1 | Cancer and epithelial uptake | Knockout and point-mutation in epithelial cell lines |
| NOG | Skeletal disorders and BMP sequestration | Knock-in of L51P-like mutations in BMP2 |
| PCOLCE | Fibrosis and matrix remodeling | Knockout in fibroblasts and matrix assays |
| TWSG1 | Developmental BMP gradient defects | Knockout in zebrafish or mouse models |
Vascular calcification and cardiovascular disease
SMOC1 regulates aortic valve calcification by disrupting BMPR-II/p-p38 signaling, linking BMP binding to cardiovascular pathology. Dysregulated BMP binding can promote ectopic calcification and valve disease, making this function a potential therapeutic target.
Cancer and epithelial cell biology
GREMLIN1 uptake in epithelial cells requires BMP binding, and this pathway may contribute to tumor progression by altering BMP signaling. BMP-binding proteins can act as oncogenes or tumor suppressors depending on context, highlighting the need for functional studies.
Fibrosis and matrix remodeling
PCOLCE is part of an extended extracellular matrix interaction network that includes BMPs, and altered BMP binding may contribute to fibrotic remodeling. Heparin-binding of BMP-2 also modulates its activity, with implications for tissue repair.
Skeletal and developmental disorders
Noggin and other BMP antagonists control BMP availability during skeletal development, and mutations affecting BMP binding can lead to skeletal abnormalities [1,5]. Twisted gastrulation is essential for proper BMP gradient formation in development.
From BMP binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a BMP-binding protein alter BMP signaling? | CRISPR knockout cell line [1,5] |
| Does a specific amino acid change affect BMP binding affinity? | Point-mutation knock-in |
| Can a tagged BMP-binding protein be tracked in live cells? | Tagged knock-in |
| Does overexpression of a BMP antagonist reduce calcification? | Overexpression model |
| Which BMP-binding proteins are essential for development? | Organoid or animal knockout |
| How does a BMP-binding protein affect matrix deposition? | Knockout in fibroblasts with matrix assays |
How to Study the BMP binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity and kinetics | Characterize BMP-heparin interactions |
| Isothermal titration calorimetry | Thermodynamics of binding | Validate BMP-2 mutant binding |
| X-ray crystallography | Atomic structure of complexes | Determine BMP-3/BMP-6 receptor interfaces |
| Molecular dynamics | Binding specificity in solution | Compare BMP-2 and BMP-9 with ALK-3 |
| BRE-luciferase reporter | BMP signaling activity | Measure effects of BMP-binding proteins |
| Western blot for p-SMAD1/5/8 | BMP pathway activation | Confirm signaling changes |
| CRISPR knockout screening | Genes required for BMP binding | Discover novel regulators [1,5] |
Biophysical binding assays
Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) are used to measure binding affinity and kinetics between BMP ligands and their partners. These methods have been applied to characterize BMP-2 binding to heparin oligosaccharides and to define minimum structural requirements. They are essential for validating structural predictions and for engineering BMP variants with altered binding properties.
Structural biology and molecular dynamics
X-ray crystallography and cryo-EM provide atomic-level views of BMP-ligand complexes, as demonstrated for BMP-3 and BMP-6. Molecular dynamics simulations complement these structures by revealing binding specificities in aqueous solution, such as BMP-2 and BMP-9 with ALK-3. These approaches inform the design of mutations that disrupt or enhance BMP binding.
Cell-based signaling assays
Luciferase reporter assays for BMP-responsive elements (BRE-luc) and Western blotting for phosphorylated SMAD1/5/8 are used to measure BMP signaling output after manipulating BMP-binding proteins. For example, SMOC1 regulation of BMPR-II/p-p38 signaling was dissected using such assays. These methods link BMP binding to functional outcomes.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for BMP binding and signaling. This approach is powerful for discovering novel regulators of BMP availability and for mapping genetic interactions [1,5]. Hits can be validated with targeted knockouts and point mutations.
How CRISPR Can Be Used to Study GO:0036122 BMP binding
Knockout
CRISPR knockout of BMP-binding genes such as NOG, GREM1, or TWSG1 can reveal their roles in BMP signaling and disease. For example, knockout of GREM1 in epithelial cells would test whether BMP binding is required for its uptake pathway. Knockout models are also used to study SMOC1 in aortic valve calcification.
Point Mutation
Point mutations can dissect the binding interface of BMP ligands or their partners. The BMP-2 mutant L51P, which binds noggin but not BMP receptor IA, was generated by a single amino acid substitution, demonstrating the power of point mutations to separate binding functions. CRISPR point-mutation knock-in can recreate such alleles in endogenous loci.
Knock-in
Knock-in of tagged versions of BMP-binding proteins (e.g., GFP or HA) allows tracking of their localization and interactions in live cells. This approach is useful for studying GREML1 uptake and trafficking. Knock-in of disease-associated mutations can also model human disorders.
Overexpression
Overexpression of BMP antagonists such as Noggin or Gremlin1 can suppress BMP signaling and is used to test therapeutic hypotheses. For instance, overexpression of SMOC1 or its mutants can modulate calcification in valve cells. Overexpression models are also valuable for producing recombinant BMP-binding proteins for structural studies.
How EDITGENE Supports BMP binding Research
Researchers studying BMP binding-related genes often need to determine whether a candidate gene is causally involved in BMP signaling, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for BMP binding research.
Frequently Asked Questions About BMP binding
What is GO:0036122?
GO:0036122 is the Gene Ontology molecular function term for BMP binding, defined as binding to a member of the bone morphogenetic protein (BMP) family [QuickGO].
What genes are involved in BMP binding?
Key genes include NOG, GREM1, TWSG1, SMOC1, PCOLCE, and BMP ligands such as BMP2, BMP3, BMP6, and BMP9 [1,2,5,6,7,8].
How does BMP binding regulate signaling?
BMP binding controls whether ligands are available to activate receptors; antagonists like Noggin sequester BMPs, while other proteins present them to receptors [1,5].
What diseases are associated with BMP binding?
Dysregulated BMP binding is linked to vascular calcification, cancer, fibrosis, and skeletal disorders [2,6].
What methods are used to study BMP binding?
Surface plasmon resonance, isothermal titration calorimetry, X-ray crystallography, molecular dynamics, and CRISPR screens are commonly used [3,4,7].
Can CRISPR be used to study BMP binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of BMP-binding proteins [1,2,5].
What is the role of Noggin in BMP binding?
Noggin is a secreted antagonist that binds BMP-2 and other BMPs, preventing receptor activation.
How does GREMLIN1 interact with BMPs?
GREMLIN1 binds BMPs, and this binding is required for its uptake in epithelial cells.
What is the structural basis of BMP binding specificity?
Specificity is determined by the complementary surfaces of BMP ligands and their binding partners, as shown for BMP-3, BMP-6, and BMP-9 [4,7].
How can I model BMP binding diseases in the lab?
EDITGENE offers CRISPR knockout, point mutation, knock-in, and overexpression cell models to study BMP binding in disease contexts [1,6].
Conclusion
GO:0036122 (BMP binding) is a fundamental molecular function that governs BMP ligand availability and signaling. Its importance spans development, tissue homeostasis, and disease, with key roles for proteins such as Noggin, Gremlin1, Twisted gastrulation, SMOC1, and PCOLCE. Understanding the structural and regulatory mechanisms of BMP binding provides opportunities for therapeutic intervention. EDITGENE's CRISPR services empower researchers to create precise cell models for dissecting BMP binding in health and disease.
References
- 1. Khattab HM et al.. 2019. The BMP-2 mutant L51P: a BMP receptor IA binding-deficient inhibitor of noggin.. J Bone Miner Metab 37(2):199-205 PMID: 29667005
- 2. Gao Z et al.. 2025. Identification of a novel GREMLIN1 uptake pathway in epithelial cells that requires BMP binding.. J Biol Chem 301(11):110780 PMID: 41033552
- 3. Smith RAA et al.. 2018. Minimum structural requirements for BMP-2-binding of heparin oligosaccharides.. Biomaterials 184:41-55 PMID: 30205243
- 4. Coskuner O et al.. 2017. BMP-2 and BMP-9 binding specificities with ALK-3 in aqueous solution with dynamics.. J Mol Graph Model 77:181-188 PMID: 28869862
- 5. Malinauskas T et al.. 2024. Molecular mechanism of BMP signal control by Twisted gastrulation.. Nat Commun 15(1):4976 PMID: 38862520
- 6. Wang Y et al.. 2022. SPARC-related modular calcium binding 1 regulates aortic valve calcification by disrupting BMPR-II/p-p38 signalling.. Cardiovasc Res 118(3):913-928 PMID: 33757126
- 7. Allendorph GP et al.. 2007. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors.. Biochemistry 46(43):12238-47 PMID: 17924656
- 8. Salza R et al.. 2014. Extended interaction network of procollagen C-proteinase enhancer-1 in the extracellular matrix.. Biochem J 457(1):137-49 PMID: 24117177
